What is Polypharmacy in Patients with Chronic Kidney Disease? A Systematic Review

Masnoon, 2017, What is polypharmacy? A systematic review of definitions, BMC Geriatr, 17, 230, 10.1186/s12877-017-0621-2 Onder, 2017, Polypharmacy, JAMA, 318, 1728, 10.1001/jama.2017.15764 Schenker, 2019, Associations Between Polypharmacy, Symptom Burden, and Quality of Life in Patients with Advanced, Life-Limiting Illness, J Gen Intern Med, 34, 559, 10.1007/s11606-019-04837-7 Wimmer, 2017, Clinical Outcomes Associated with Medication Regimen Complexity in Older People: A Systematic Review, J Am Geriatr Soc, 65, 747, 10.1111/jgs.14682 Lau, 2005, Hospitalization and Death Associated With Potentially Inappropriate Medication Prescriptions Among Elderly Nursing Home Residents, Arch Intern Med, 165, 68, 10.1001/archinte.165.1.68 Wilson, 2021, Chronic kidney disease: Definition, updated epidemiology, staging, and mechanisms of increased cardiovascular risk, J Clin Hypertens, 23, 831, 10.1111/jch.14186 Bailie, 2005, Patterns of medication use in the RRI-CKD study: focus on medications with cardiovascular effects, Nephrol Dial Transplant, 20, 1110, 10.1093/ndt/gfh771 Kinugasa, 2020, Polypharmacy and taste disorders in heart failure patients, Eur J Prev Cardiol, 27, 110, 10.1177/2047487319856717 Danjuma, 2023 Page, 2021, The PRISMA 2020 statement: an updated guideline for reporting systematic reviews, BMJ, n71, 10.1136/bmj.n71 Loney, 1998, Critical appraisal of the health research literature: prevalence or incidence of a health problem, Chronic Dis Can J, 19, 170 Kang, 2019, Risk of Kidney Dysfunction from Polypharmacy among Older Patients: A Nested Case-Control Study of the South Korean Senior Cohort, Sci Rep, 9, 10440, 10.1038/s41598-019-46849-7 Kimura, 2021, Association of Polypharmacy with Kidney Disease Progression in Adults with CKD, Clin J Am Soc Nephrol, 16, 1797, 10.2215/CJN.03940321 Yameen, 2021, Trends in Prescribing Patterns and Drug Related Problems of Kidney Disease Patients, J Pak Med Assoc, 71, 2629, 10.47391/JPMA.01816 Lobos-Bejarano, 2017, Influence of renal function on anticoagulation control in patients with non-valvular atrial fibrillation taking vitamin K antagonists, Int J Clin Pract, 71, e12974, 10.1111/ijcp.12974 Sutaria, 2016, Multiple medication (polypharmacy) and chronic kidney disease in patients aged 60 and older: a pharmacoepidemiologic perspective, Ther Adv Cardiovasc Dis, 10, 242, 10.1177/1753944716634579 König, 2017, Prevalence of Impaired Kidney Function in the German Elderly: Results from the Berlin Aging Study II (BASE-II), Gerontology, 63, 201, 10.1159/000454831 Formica, 2018, Acute Kidney Injury and Chronic Kidney Disease in the Elderly and Polypharmacy, Blood Purif, 46, 332, 10.1159/000492149 Garedow, 2019, Drug-Related Problems and Associated Factors among Patients Admitted with Chronic Kidney Disease at Jimma University Medical Center, Jimma Zone, Jimma, Southwest Ethiopia: A Hospital-Based Prospective Observational Study, Int J Nephrol, 2019, 1, 10.1155/2019/1504371 Dias, 2019, Potential drug interactions in drug therapy prescribed for older adults at hospital discharge: cross-sectional study, Sao Paulo Med J, 137, 369, 10.1590/1516-3180.2019.013405072019 Schmidt, 2019, Patterns of medication use and the burden of polypharmacy in patients with chronic kidney disease: the German Chronic Kidney Disease study, Clin Kidney J, 12, 663, 10.1093/ckj/sfz046 Villén, 2020, Multimorbidity patterns, polypharmacy and their association with liver and kidney abnormalities in people over 65 years of age: a longitudinal study, BMC Geriatr, 20, 206, 10.1186/s12877-020-01580-1 Santos-Díaz, 2020, Prevalence of Potential Drug–Drug Interaction Risk among Chronic Kidney Disease Patients in a Spanish Hospital, Pharmaceutics, 12, 713, 10.3390/pharmaceutics12080713 Ramírez, 2013, Drug-induced life-threatening potassium disturbances detected by a pharmacovigilance program from laboratory signals, Eur J Clin Pharmacol, 69, 97, 10.1007/s00228-012-1303-9 Subeesh, 2020, Evaluation of prescribing practices and drug-related problems in chronic kidney disease patients: A cross-sectional study, Perspect Clin Res, 11, 70, 10.4103/picr.PICR_110_18 Min, 2021, Polypharmacy and the Progression of Chronic Kidney Disease: Korean Cohort Study for Outcome in Patients with Chronic Kidney Disease, Kidney Blood Press Res, 46, 460, 10.1159/000516029 Molnar, 2020, Potentially inappropriate prescribing in older adults with advanced chronic kidney disease, PLOS ONE, 15, 10.1371/journal.pone.0237868 Bowling, 2014, Nondisease-Specific Problems and All-Cause Mortality among Older Adults with CKD: The REGARDS Study, Clin J Am Soc Nephrol, 9, 1737, 10.2215/CJN.00880114 Barnsteiner. Medication Reconciliation. In: Cover of Patient Safety and Quality Patient Safety and Quality An Evidence-Based Handbook for Nurses. https://www.ncbi.nlm.nih.gov/books/NBK2648/ Chang, 2020, Polypharmacy, hospitalization, and mortality risk: a nationwide cohort study, Sci Rep, 10, 18964, 10.1038/s41598-020-75888-8 Danjuma, 2022, What is polypharmacy in people living with HIV/AIDS? A systematic review, AIDS Res Ther, 19, 37, 10.1186/s12981-022-00461-4 Belachew, 2023, Misunderstanding of dosing regimen instructions among patients with chronic diseases receiving polypharmacy at the University of Gondar comprehensive specialized hospital, PLoS One, 18, 10.1371/journal.pone.0280204 Mangoni, 2003, Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications, Br J Clin Pharmacol, 57, 6, 10.1046/j.1365-2125.2003.02007.x